| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Urology & Nephrology |
| Manuscript Type |
Scientometrics |
| Article Title |
What should be the future direction of development in the field of prostate cancer with lung metastasis?
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Zhi-Guang Huang, Yi Chen, Tong Wu, Bin-Tong Yin, Xiao Feng, Sheng-Hua Li, Dong-Ming Li, Gang Chen, Ji-Wen Cheng and Juan He |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Natural Science Foundation of Guangxi, China |
2020GXNSFBA238017 |
| Guangxi Zhuang Autonomous Region Health Commission Self-financed Scientific Research Project |
Z20200963 |
|
| Corresponding Author |
Juan He, MM, Doctor, Doctor, Department of Pathology, First Affiliated Hospital of Guangxi Medical University, No. 6 Shuangyong Road, Nanning 530021, Guangxi Zhuang Autonomous Region, China. hejuan@stu.gxmu.edu.cn |
| Key Words |
Prostate cancer; Lung metastasis; Chemotherapy; Immunotherapy; Bibliometric analysis; Enrichment analysis |
| Core Tip |
Discovering new insights into prostate cancer with lung metastasis (PCLM), this study presents a systematic analysis of 280 high-quality papers and global datasets. The uneven distribution of PCLM research is highlighted. Notably, this study uncovers the association of PCLM with pathways related to coronavirus disease 2019, cytokine-cytokine receptor interaction, and ribosomes. While traditional treatments remain crucial, novel approaches like immunotherapy show limited effectiveness. Future research should prioritize exploring mechanisms such as cytokine-cytokine receptor interaction and ribosomes while enhancing existing mechanisms like cell adhesion molecules. This study’s innovative findings contribute to the advancement of PCLM research, stimulating further exploration and potential improvements in diagnosis and treatment strategies. |
| Publish Date |
2023-10-24 07:40 |
| Citation |
Huang ZG, Chen Y, Wu T, Yin BT, Feng X, Li SH, Li DM, Chen G, Cheng JW, He J. What should be the future direction of development in the field of prostate cancer with lung metastasis? World J Clin Oncol 2023; 14(10): 420-439 |
| URL |
https://www.wjgnet.com/2218-4333/full/v14/i10/420.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v14.i10.420 |
